Neurosurgical approaches: Drug infusion directly into the parenchyma or the cerebrospinal fluid

AAPS Advances in the Pharmaceutical Sciences Series

Volumn 10, Issue , 2014, Pages 501-518

  Bankiewicz, Krystof ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; GADOTERIDOL; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LIPOSOME; NANOPARTICLE; PENTETIC ACID; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS 9; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CLINICAL TRIAL (TOPIC); CONVECTION ENHANCED DRUG DELIVERY; CORPUS STRIATUM; DRUG DELIVERY SYSTEM; DRUG INFUSION; GENE THERAPY; HUMAN; LYSOSOME STORAGE DISEASE; MUCOPOLYSACCHARIDOSIS; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PRIORITY JOURNAL; SPINAL MUSCULAR ATROPHY; VENTRICULAR CANNULA (BRAIN);

EID: 85065457792     PISSN: 22107371     EISSN: 2210738X     Source Type: Book Series    
DOI: 10.1007/978-1-4614-9105-7_18     Document Type: Article

References (75)

1. Bobo RH, Laske DW et al (1994) Convection-enhanced delivery of macromolecules in the brain.Proc Natl Acad Sci U S A 91(6):2076–2080
2. Cabrera-Salazar MA, Bercury SD et al (2010) Intracerebroventricular delivery of glucocerebrosidase reduces substrates and increases lifespan in a mouse model of neuronopathic Gaucher disease.Exp Neurol 225:436–444
3. Carson BS Sr, Wu Q et al (2002) New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery. J Neurooncol 60(2):151–158
4. Chang M, Cooper JD et al (2008) Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis. Mol Ther 16(4):649–656
5. Chen M Y, Lonser RR et al (1999) Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg 90(2):315–320
6. Christine CW, Starr PA et al (2006) Aromatic L-amino acid decarboxylase gene transfer therapy for Parkinson’s disease: initial results of an open-label, dose escalation, safety and tolerability study. Abstract S23.005. American Academy of Neurology, San Diego, CA
7. Dickinson PJ, LeCouteur RA et al (2008) Canine model of convection-enhanced delivery of lipo-somes containing CPT-11 monitored with real-time magnetic resonance imaging: laboratory investigation. J Neurosurg 108(5):989–998
8. Dickson P, McEntee M et al (2007) Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fl uid. Mol Genet Metabol 91:61–68
9. Dodge JC, Clarke J et al (2008) Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann–Pick A disease. Exp Neurol 215:349–357
10. Eberling JL, Jagust WJ et al (2008) Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology 70(21):1980–1983
11. Fiandaca MS, Forsayeth JR et al (2008) Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics 5(1):123–127
12. Fiandaca MS, Varenika V et al (2009) Real-time MR imaging of adeno-associated viral vector delivery to the primate brain. Neuroimage 47(Suppl 2):T27–T35
13. Foust KD, Nurre E et al (2009) Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27(1):59–65
14. Gash DM, Zhang Z et al (1996) Functional recovery in parkinsonian monkeys treated with GDNF.Nature 380(6571):252–255
15. Gill SS, Patel NK et al (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9(5):589–595
16. Gimenez F, Krauze MT et al (2011) Image-guided convection-enhanced delivery of GDNF protein into Monkey Putamen. Neuroimage 54(1):S189–195
17. Gray SJ, Matagne V et al (2011) Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol Ther 19(6):1058–1069
18. Grondin R, Zhang Z et al (2002) Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain 125(Pt 10):2191–2201
19. Hadaczek P, Mirek H et al (2006) “Perivascular pump” driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Mol Ther 14(1):69–78
20. Hall WA, Liu H et al (2001) Brain biopsy sampling by using prospective stereotaxis and a trajectory guide. J Neurosurg 94(1):67–71
21. Hamilton JF, Morrison PF et al (2001) Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin. Exp Neurol 168(1):155–161
22. Hemsley KM, Beard H et al (2008) Effect of high dose, repeated intra-cerebrospinal fl uid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice. Genes Brain Behav 7:740–753
23. Hemsley KM, King B et al (2007) Injection of recombinant human sulfamidase into the CSF via the cerebellomedullrry cistern in MPS IIIA mice. Mol Genet Metab 90:313–328
24. Hemsley KM, Norman EJ et al (2009) Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs—a proof of principle study. Mol Genet Metabol 98:383–392
25. Kordower JH, Palfi S et al (1999) Clinicopathological fi ndings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson’s disease. Ann Neurol46(3):419–424
26. Krauze MT, Forsayeth J et al (2006) Real-time imaging and quantifi cation of brain delivery of liposomes. Pharm Res 23(11):2493–2504
27. Krauze MT, McKnight TR et al (2005a) Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Res Brain Res Protoc16:20–26
28. Krauze MT, Saito R et al (2005b) Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen. Exp Neurol 196(1):104–111
29. Krauze MT, Saito R et al (2005c) Refl ux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg 103(5):923–929
30. Kroll RA, Pagel MA et al (1996) Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor. Neurosurgery 38(4):746–752, discussion 752–754
31. Kunwar S (2003) Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim fi ndings from ongoing phase 1 studies. Acta Neurochir Suppl 88:105–111
32. Kunwar S, Prados MD et al (2007) Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol 25(7):837–844
33. Lang AE, Gill S et al (2006) Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol 59(3):459–466
34. Lee WC, Tsoi YK et al (2007) Single-dose intracerebroventricular administration of galactocer-ebrosidase improves survival in a mouse model of globoid cell leukodystrophy. FASEB J 21(10):2520–2527
35. Lonser RR, Corthesy ME et al (1999) Convection-enhanced selective excitotoxic ablation of the neurons of the globus pallidus internus for treatment of parkinsonism in nonhuman primates. J Neurosurg 91(2):294–302
36. Lonser RR, Schiffman R et al (2007) Image-guided, direct convective delivery of glucocerebrosi-dase for neuronopathic Gaucher disease. Neurology 68(4):254–261
37. Mardor Y, Roth Y et al (2001) Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res 61(13): 4971–4973
38. Marks WJ, Bartus RT et al (2010) Gene delivery of AAV2-neurturin for Parkinson’s disease: a double-blind, randomised, controlled trial. Lancet Neurol 9:1164–1172
39. Martin AJ, Hall WA et al (2008) Minimally invasive precision brain access using prospective stereotaxy and a trajectory guide. J Magn Reson Imaging 27(4):737–743
40. Martin AJ, Larson PS et al (2005) Placement of deep brain stimulator electrodes using real-time high-fi eld interventional magnetic resonance imaging. Magn Reson Med 54(5):1107–1114
41. Morrison PF, Chen MY et al (1999) Focal delivery during direct infusion to brain: role of fl ow rate, catheter diameter, and tissue mechanics. Am J Physiol 277(4 Pt 2):R1218–R1229
42. Murad GJ, Walbridge S et al (2006) Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to pseudomonas exotoxin. Clin Cancer Res 12(10):145–151
43. Murad GJ, Walbridge S et al (2007) Image-guided convection-enhanced delivery of gemcitabine to the brainstem. J Neurosurg 106(2):351–356
44. Neeves KB, Sawyer AJ et al (2007) Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles. Brain Res 1180:121–132
45. Nguyen JB, Sanchez-Pernaute R et al (2001) Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain. Neuroreport 12(9):1961–1964
46. Nguyen TT, Pannu YS et al (2003) Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. J Neurosurg 98(3):584–590
47. Nutt JG, Burchiel KJ et al (2003) Randomized, double-blind trial of glial cell line-derived neuro-trophic factor (GDNF) in PD. Neurology 60(1):69–73
48. Richardson RM, Kells AP et al (2011) Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain. Stereotact Funct Neurosurg 89(3):141–151
49. Richardson RM, Larson PS et al (2008) Gene and cell delivery to the degenerated striatum: status of preclinical efforts in primate models. Neurosurgery 63(4):629–642, dicussion 642–644
50. Richardson RM, Varenika V et al (2009) Future applications: gene therapy. Neurosurg Clin N Am 20(2):205–210
51. Rosenbluth KH, Eschermann JF et al (2012a) Analysis of a simulation algorithm for direct brain drug delivery. Neuroimage 59(3):2423–2429
52. Rosenbluth KH, Martin AJ et al (2012b) Evaluation of pressure-driven brain infusions in nonhu-man primates by intra-operative 7 Tesla MRI. J Magn Reson Imaging 36(6):1339–1346
53. Rosenbluth KH, Luz M et al (2011) Design of an in-dwelling cannula for convection-enhanced delivery. J Neurosci Methods 196(1):118–123
54. Rosenbluth KH, Martin AJ et al (2013) Rapid inverse planning for pressure-driven drug infusions in the brain. PLoS One 8(2):e56397
55. Saito R, Krauze MT et al (2005) Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Exp Neurol 196(2):381–389
56. Samaranch L, Salegio EA et al (2013) Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fl uid of nonhuman primates. Hum Gene Ther 24(5): 526–532
57. Samaranch L, Salegio EA et al (2012) Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther 23(4):382–389
58. Sampson JH, Akabani G et al (2003) Progress report of a phase I study of the intracerebral micro-infusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors. J Neurooncol 65(1):27–35
59. Sanftner LM, Sommer JM et al (2005) AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters. Exp Neurol 194(2):476–483
60. Slevin JT, Gash DM et al (2006) Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal. Neurosurg Focus 20(5):E1
61. Starr PA, Martin AJ et al (2010) Subthalamic nucleus deep brain stimulator placement using high-fi eld interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy. J Neurosurg 112(3):479–490
62. Su X, Kells AP et al (2010) Real-time MR imaging with gadoteridol predicts distribution of trans-genes after convection-enhanced delivery of AAV2 vectors. Mol Ther 18(8):1490–1495
63. Sykova E (2004) Diffusion properties of the brain in health and disease. Neurochem Int 45(4):453–466
64. Szerlip NJ, Walbridge S et al (2007) Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles. J Neurosurg 107(3):560–567
65. Truwit CL, Liu H (2001) Prospective stereotaxy: a novel method of trajectory alignment using real-time image guidance. J Magn Reson Imaging 13(3):452–457
66. Valles F, Fiandaca MS et al (2010) Qualitative imaging of adeno-associated virus serotype 2-human aromatic l -amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease. Neurosurgery 67(5):1377–1385
67. Varenika V, Dickenson P et al (2008) Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery. J Neurosurg 109:874–880
68. Yin D, Forsayeth J et al (2010a) Optimized cannula design and placement for convection-enhanced delivery in rat striatum. J Neurosci Methods 187(1):46–51
69. Yin D, Richardson RM et al (2010) Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics. J Neurosurg 113(2):240–248
70. Yin D, Richardson RM et al (2010b) Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics. J Neurosurg 113(2):240–248
71. Yin D, Valles FE et al (2011) Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates. Neuroimage 54(1):S196–203
72. Yin D, Valles FE et al (2009a) Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates. Neuroimage
73. Yin D, Valles FE et al (2009b) Striatal volume differences between non-human and human primates. J Neurosci Methods 176(2):200–205
74. Zhang Z, Miyoshi Y et al (1997) Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys. J Pharmacol Exp Ther 282(3):1396–1401
75. Ziegler RJ, Salegio EA et al (2011) Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion. Exp Neurol 231(2):261–271